Cited by 127

The DOI matches its Crossref record; 5 of the 5 references it cites were found in a registry or an index.

Transient and Permanent Reconfiguration of Chromatin and Transcription Factor Occupancy Drive Reprogramming

Knaupp, Anja S., Buckberry, Sam, Pflueger, Jahnvi, Lim, Sue Mei, Ford, Ethan, Larcombe, Michael R., Rossello, Fernando J., de Mendoza, Alex, Alaei, Sara, Firas, Jaber, Holmes, Melissa L., Nair, Shalima S., Clark, Susan J., Nefzger, Christian M., Lister, Ryan, Polo, Jose M.·2017·Cell Stem Cell

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.stem.2017.11.007

Cites

5 of 5 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • In mouse embryonic fibroblasts (MEFs), OCT4 binds somatic enhancers during reprogramming and may initiate their inactivation, whereas in human fetal fibroblasts, OCT4 and SOX2 bind putative enhancers and remain bound in iPS cells.

    “Specifically, in mouse embryonic fibroblasts (MEFs), OCT4 binds somatic enhancers during reprogramming and may initiate their inactivation, whereas in human fetal fibroblasts, OCT4 and SOX2 bind putative enhancers and remain bound in iPS cells.”

    From Mechanisms, pathways and strategies for rejuvenation through epigenetic reprogramming (2023) · cites this paper as [81]

    The Discussion (page unavailable) reports Oct4/Sox2 binding at some regions open in MEFs, but it does not establish that Oct4 initiates somatic-enhancer inactivation; it says MEF enhancers can lose accessibility independently of Oct4/Sox2. The Introduction mentions human reprogramming studies, but our copy does not report the claimed persistent binding at putative enhancers in human fetal fibroblasts and their iPS cells. (LLM, conf=0.85)

    Experimental — accuracy not yet measured
  • OSK factors interact with the genome and each other differently in mice than in human cells.

    “OSK factors interact with the genome and each other differently in mice than in human cells [80][81][82] , complicating the design and interpretation of studies.”

    From Mechanisms, pathways and strategies for rejuvenation through epigenetic reprogramming (2023) · cites this paper as [81]

    The Introduction (page not available) describes conflicting reports of OSK chromatin targeting in mouse and human reprogramming studies, supporting a reported difference in genome interactions. It does not establish a species-specific difference in how OSK factors interact with one another; the Discussion (page not available) also reports mouse results consistent with pioneer-factor activity, so the contrast is less settled than the claim suggests. (LLM, conf=0.84)

    Experimental — accuracy not yet measured
  • Early events in reprogramming are largely transient, so critical transitional OSKM-chromatin dynamics during such events are probably missing.

    “As the early events in reprogramming are largely transient 81 , we are probably missing critical transitional OSKM-chromatin dynamics during such events, leaving mechanistic questions largely unanswered.”

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Flagged first, then by citations

Research works printed but not linked: 38

  1. Ahmed, 2010, Global chromatin architecture reflects pluripotency and lineage commitment in the early mouse embryo, PLoS ONE, 5, e10531, 10.1371/journal.pone.0010531 · DOI
  2. Alaei, 2016, An improved reprogrammable mouse model harbouring the reverse tetracycline-controlled transcriptional transactivator 3, Stem Cell Res. (Amst.), 17, 49, 10.1016/j.scr.2016.05.008 · DOI
  3. Alexandrova, 2013, ΔNp63 regulates select routes of reprogramming via multiple mechanisms, Cell Death Differ., 20, 1698, 10.1038/cdd.2013.122 · DOI
  4. Bailey, 2012, Inferring direct DNA binding from ChIP-seq, Nucleic Acids Res., 40, e128, 10.1093/nar/gks433 · DOI
  5. Buenrostro, 2013, Transposition of native chromatin for fast and sensitive epigenomic profiling of open chromatin, DNA-binding proteins and nucleosome position, Nat. Methods, 10, 1213, 10.1038/nmeth.2688 · DOI · Paper page
  6. Chen, 2010, BS Seeker: Precise mapping for bisulfite sequencing, BMC Bioinformatics, 11, 203, 10.1186/1471-2105-11-203 · DOI
  7. Chen, 2016, Hierarchical Oct4 binding in concert with primed epigenetic rearrangements during somatic cell reprogramming, Cell Rep., 14, 1540, 10.1016/j.celrep.2016.01.013 · DOI · Paper page
  8. Chia, 2010, A genome-wide RNAi screen reveals determinants of human embryonic stem cell identity, Nature, 468, 316, 10.1038/nature09531 · DOI
  9. Efroni, 2008, Global transcription in pluripotent embryonic stem cells, Cell Stem Cell, 2, 437, 10.1016/j.stem.2008.03.021 · DOI
  10. 2012, An integrated encyclopedia of DNA elements in the human genome, Nature, 489, 57, 10.1038/nature11247 · DOI · Paper page
  11. Feng, 2012, Identifying ChIP-seq enrichment using MACS, Nat. Protoc., 7, 1728, 10.1038/nprot.2012.101 · DOI
  12. Heinz, 2010, Simple combinations of lineage-determining transcription factors prime cis-regulatory elements required for macrophage and B cell identities, Mol. Cell, 38, 576, 10.1016/j.molcel.2010.05.004 · DOI · Paper page
  13. Ho, 2013, Stage-specific regulation of reprogramming to induced pluripotent stem cells by Wnt signaling and T cell factor proteins, Cell Rep., 3, 2113, 10.1016/j.celrep.2013.05.015 · DOI
  14. Hussein, 2014, Genome-wide characterization of the routes to pluripotency, Nature, 516, 198, 10.1038/nature14046 · DOI · Paper page
  15. Kim, 2015, HISAT: A fast spliced aligner with low memory requirements, Nat. Methods, 12, 357, 10.1038/nmeth.3317 · DOI · Paper page
  16. Koche, 2011, Reprogramming factor expression initiates widespread targeted chromatin remodeling, Cell Stem Cell, 8, 96, 10.1016/j.stem.2010.12.001 · DOI · Paper page
  17. Kumar, 2007, Mfuzz: A software package for soft clustering of microarray data, Bioinformation, 2, 5, 10.6026/97320630002005 · DOI
  18. Langmead, 2009, Ultrafast and memory-efficient alignment of short DNA sequences to the human genome, Genome Biol., 10, R25, 10.1186/gb-2009-10-3-r25 · DOI · Paper page
  19. Law, 2014, voom: Precision weights unlock linear model analysis tools for RNA-seq read counts, Genome Biol., 15, R29, 10.1186/gb-2014-15-2-r29 · DOI · Paper page
  20. Lawrence, 2013, Software for computing and annotating genomic ranges, PLoS Comput. Biol., 9, e1003118, 10.1371/journal.pcbi.1003118 · DOI
  21. Lee, 2014, An epigenomic roadmap to induced pluripotency reveals DNA methylation as a reprogramming modulator, Nat. Commun., 5, 5619, 10.1038/ncomms6619 · DOI · Paper page
  22. Li, 2010, RNA-Seq gene expression estimation with read mapping uncertainty, Bioinformatics, 26, 493, 10.1093/bioinformatics/btp692 · DOI · Paper page
  23. Liu, 2015, The oncogene c-Jun impedes somatic cell reprogramming, Nat. Cell Biol., 17, 856, 10.1038/ncb3193 · DOI
  24. Mathelier, 2016, JASPAR 2016: A major expansion and update of the open-access database of transcription factor binding profiles, Nucleic Acids Res., 44, D110, 10.1093/nar/gkv1176 · DOI · Paper page
  25. Meshorer, 2006, Hyperdynamic plasticity of chromatin proteins in pluripotent embryonic stem cells, Dev. Cell, 10, 105, 10.1016/j.devcel.2005.10.017 · DOI
  26. Minajigi, 2015, Chromosomes. A comprehensive Xist interactome reveals cohesin repulsion and an RNA-directed chromosome conformation, Science, 349, 10.1126/science.aab2276 · DOI
  27. Nefzger, 2014, Cell surface marker mediated purification of iPS cell intermediates from a reprogrammable mouse model, J. Vis. Exp., 10.3791/51728 · DOI
  28. Nefzger, 2017, Cell type of origin dictates the route to pluripotency, Cell Rep, 21, 10.1016/j.celrep.2017.11.029 · DOI
  29. O’Malley, 2013, High-resolution analysis with novel cell-surface markers identifies routes to iPS cells, Nature, 499, 88, 10.1038/nature12243 · DOI
  30. Pages, 2008, Biostrings: String objects representing biological sequences, and matching algorithms, 2008, R Package Version, 2, 160
  31. Ramírez, 2014, deepTools: A flexible platform for exploring deep-sequencing data, Nucleic Acids Res., 42, W187, 10.1093/nar/gku365 · DOI · Paper page
  32. Robinson, 2010, edgeR: a Bioconductor package for differential expression analysis of digital gene expression data, Bioinformatics, 26, 139, 10.1093/bioinformatics/btp616 · DOI · Paper page
  33. Schep, 2015, Structured nucleosome fingerprints enable high-resolution mapping of chromatin architecture within regulatory regions, Genome Res., 25, 1757, 10.1101/gr.192294.115 · DOI · Paper page
  34. Soufi, 2012, Facilitators and impediments of the pluripotency reprogramming factors’ initial engagement with the genome, Cell, 151, 994, 10.1016/j.cell.2012.09.045 · DOI · Paper page
  35. Takahashi, 2006, Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors, Cell, 126, 663, 10.1016/j.cell.2006.07.024 · DOI · Paper page
  36. Tarasov, 2015, Sambamba: fast processing of NGS alignment formats, Bioinformatics, 31, 2032, 10.1093/bioinformatics/btv098 · DOI
  37. Urich, 2015, MethylC-seq library preparation for base-resolution whole-genome bisulfite sequencing, Nat. Protoc., 10, 475, 10.1038/nprot.2014.114 · DOI
  38. Yeom, 1996, Germline regulatory element of Oct-4 specific for the totipotent cycle of embryonal cells, Development, 122, 881, 10.1242/dev.122.3.881 · DOI

Cited by

Sorted by citations

Metadata

Authors
Knaupp, A. S., Buckberry, S., Pflueger, J., Lim, S. M., Ford, E., Larcombe, M. R., Rossello, F. J., de Mendoza, A., Alaei, S., Firas, J., Holmes, M. L., Nair, S. S., Clark, S. J., Nefzger, C. M., Lister, R., & Polo, J. M.
Venue
Cell Stem Cell
Publisher
Elsevier BV
Published
2017-12
Volume
21
Issue
6
Pages
834-845.e6
ISSN
1934-5909
Cited by
127
References
5
Language
en
Funders
  • National Health and Medical Research Council (NHMRC) of Australia (GNT1069830)
  • Australian Research Council (ARC) Centre of Excellence program in Plant Energy Biology (CE140100008)
  • ARC
  • Sylvia and Charles Viertel Senior Medical Research Fellowships
  • NHMRC CDF (APP1036587)
  • ARC Future Fellowship (FT120100862)
  • Howard Hughes Medical Institute International Research Scholarship
  • NHMRC-ARC Dementia Research Development Fellowship (APP1111206)
  • NHMRC Early Career Fellowship (APP1092280)

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review